INON ACE Antacid tablets (magnesium aluminosilicate, magnesium hydroxide and simethicone), 75-count bottle, Manufactured by: Sato Pharmaceutical Co., Ltd., NDC 49873-402-01
FDA recall notice · announced February 4, 2026 · Sato Pharmaceutical Co
Class II FDA/FSIS Class II: use may cause temporary or medically reversible adverse health consequences.
The product
INON ACE Antacid tablets (magnesium aluminosilicate, magnesium hydroxide and simethicone), 75-count bottle, Manufactured by: Sato Pharmaceutical Co., Ltd., NDC 49873-402-01
Reason for recall
Failed Disintegration Specifications: above the time expected.
Notes
Distribution: CA and HI
Lot/code information: Lot#: PWXT, Exp 1/31/2027
Quantity: 3,640 bottles
Status: Ongoing
Products in this recall event:
- INON ACE Antacid tablets (magnesium aluminosilicate, magnesium hydroxide and simethicone), 75-count bottle, Manufactured by: Sato Pharmaceutical Co., Ltd., NDC 49873-402-01 (D-0298-2026)
Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.